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This edition of
Advance highlights
the emphasis
on research that
ultimately affects
patient care and
clinical outcomes in
areas where we have
exceptional medical
expertise that has
earned regional
and national
recognition. The research in the core laboratories of
biomedical engineering, vascular diseases and molecular
imaging are closely allied to and support advanced
and skilled clinical care given in the Stroke Center, the
Brain and Spine Institute, The Heart, Lung, Vascular
Institute, Neonatal Intensive Care Unit, and the Cancer
Institute. Other efforts, such as the anesthesia clotting
laboratory, have contributed significantly to how
we address clotting abnormalities in massive trauma
injuries, post-partum hemorrhage and other situations
where appropriate blood component replacement is
necessary. Nikki Zite, M.D., and Audrey Barry, M.D.,
highlight geographic location of patients and subsequent
cost factors that play a role in access to medical care,
underlining a major socioeconomic impediment to the
delivery of obstetrical care seen in the Women’s Center.
Stephen Kennel, Ph.D., is exploring more effective
ways to treat cancer through modern nanotechnology.
Many of the highlighted efforts represent work that is
done in collaboration with other nationally recognized
institutions while others are singular to our institution.
All of these areas of research will have an impact on how
we care for patients, putting University of Tennessee
Medical Center on track to delve into the kind of
advanced medical care that attracts national attention.
This recognition leads not only to better care for our
patients, but it also helps recruit physicians who give
expert care and who are on the forefront of innovations
leading to better care. Additionally, it helps recruit
higher quality residents and students who ask questions
that make us uncomfortable with the status quo in some
areas and force us to look for new solutions. Someone
once suggested to me, that a physician who taught or
did research only did so because he or she couldn’t give
proper clinical care. On the contrary, the physicians at
UTMCK do all three expertly. Our clinicians practice,
teach and seek solutions for the complex problems
presented by clinical situations.
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This is the final issue under the direction of Amanda
Johnson as managing editor. We would like to recognize
her for her professionalism, creativity and editorial
expertise. She was a credit to the Graduate School of
Medicine and will be missed. We wish her well in her
new position. Kristen Bass and Brittany Nauta will take
over editorial duties.

Wisdom for Your Life.
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featured researchers

»»»»»»

At the end of the day, physician-researchers Nikki Zite and Wes White are a married couple who also are mom and dad
to sons Jackson and Grayson (and a playful dog, Cleo).

She was a chief resident far from home and
passionate about women’s health. He was a
third-year medical student transplanted from
Knoxville and eager to excel. In the midst of the
caffeine-rich environment of medical school and
residency training, these two determined young
professionals met.
“It sounds much more ‘Grey’s Anatomy’ than it
actually was,” laughs Nikki Zite, M.D., about the
popular television drama.
Without Hollywood’s help, the two met, and a
collaboration of the truest kind began.
“We were engaged by the time I finished
medical school,” remembers Wes White, M.D.
Today, Zite is an associate professor and
residency program director in the Department
of Obstetrics/Gynecology.  White is an assistant
professor in the Department of Surgery and
director of the Division of Laparoscopic and

Robotic Surgery in the Department of Urology.
At the end of the day, though, they become just
husband and wife, mom and dad.
Zite and White sit comfortably together on
the squishy sofa on their porch. Their two boys,
Jackson, 6, and Grayson, 4, topple onto their
laps, keen to hear about their parents’ experiences
at work. Cleo, their black Labrador retriever,
demonstrates her enthusiasm.
In this familial chaos and after spending a
day delivering babies, performing surgery and
advancing research and educational programs, Zite
and White are calm and attentive, even with Cleo.
Their backgrounds and medical specialties
differ, but one thing is identical: Both physicians
are avid about the patients they care for, the
residents they teach and the research they conduct.
Although they collaborate on an ongoing
study about kidney stones during pregnancy, their
2

Wes White, M.D., focuses research effort on robotics
and laparoscopic surgery.

Nikki Zite, M.D., avidly researches disparities in women’s
health care.

research rarely intertwines. Zite
focuses her research on contraception, sterilization
and health disparities; while White researches
robotics, laparoscopy and laparoendoscopic singlesite surgery.
“I have a built-in sounding board,” White says
of his wife who in addition to being a medical
doctor is trained in public health. “It’s nice to
be able to sit on the sofa and read my research to
Nikki. She’s good with study design.”
White, the first Urology resident at the
Graduate School of Medicine in 2004, says he
wants to give back to a program that was good to
him. He dedicates each Friday to research and
seeks novel perspectives from which to approach
a medical issue. Currently, he is working with
the UT Knoxville College of Business to build a
predictive model to determine patient outcomes,
particularly in relation to prostate cancer diagnosis
and treatment.
About her work, Zite says, “I really like taking
care of patients, and working on improving public

health issues. I hope to continue to do research
until we figure out a better way to provide care
for women with socioeconomic limitations.” [See
related story page 11.]
Zite researches ways to debunk myths from
the 1970s about the safety of IUDs (intrauterine
devices) in women who have never delivered a
baby, and she promotes sterilization for women on
Medicaid/Tenncare who opt for the procedure.
“It’s a national issue,” Zite says. “We are
working to get the attention of the right people.”
Just then Jackson’s ball goes off course, and
Grayson stomps into the room, temporarily upset.  
So, do these doctors/researchers/teachers/parents
want their children to become doctors?
“Statistics tell us one of them probably will,”
says the dad, reluctantly.
To which the mom adds calmly, “We want
them to do what fulfills them.”
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Collaborative New
Bridges Engineerin

Christopher Stephens, Ph.D., (left) and Emam Fatah, Ph.D., are examining clinical pathways.

There’s a new collaboration in town.
This partnership joins pocket protectors
and stethoscopes, data and diagnoses. The
collaboration, called the Institute of Biomedical
Engineering, aligns the best of the UT College
of Engineering with the Graduate School of
Medicine and College of Veterinary Medicine to
develop unique approaches to patient care.
Skeptical? Keep reading.

Ph.D., the director of the Institute of Biomedical
Engineering and professor of biomedical
engineering, received funding from the National
Institutes of Health to develop a tool to diagnose
lower back pain. His device is smaller than a
cell phone, noninvasive and analyzes patterns of
motion in everyday movement.
For the rest of the story, visit
http://gsm.utmck.edu/research/ibme/main.cfm

Physics and Lower Back Pain
Lower back pain
is not just a pain
in the neck; it’s
also the second
leading cause for
physician visits in
the U.S., reports
the American
Chiropractic
Association. The
most popular diagnostic method is imaging, but
x-ray, CT and MRI scans are static and cannot
provide quantitative dynamic information. For
anyone who suffers from recurrent lower back
pain, an undiagnosed source of the pain rapidly
deteriorates quality of life.
About five years ago, Mohamed Mahfouz,

Pushing Ultrasound Beyond
the Boundaries

Mahfouz and team also are expanding the
boundaries of ultrasound, transforming a helpful
2D image into a revealing 3D image, and
anyone who receives injections in their joints will
welcome this technology.
Ultrasound is often preferred because it does
not use radiation, and it provides immediate
feedback. Its limited imaging capability,
4
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ng and Medicine

For the rest of the story, visit
http://gsm.utmck.edu/research/ibme/main.cfm

however, can create difficulties for certain
medical procedures. To address this need, the
team created innovative software that combines
the radiofrequency signal of ultrasound with an
original algorithm and knowledge of anatomy
to “complete the picture.” Where ultrasound
doesn’t see, the software fills in the bone’s image,
even if the bone is malformed.
For the rest of the story, visit http://gsm.
utmck.edu/research/ibme/main.cfm

Knoxville, Meet the Future
The future of
surgical imaging is
being developed today,
and it’s about the size
of an almond. The
sCam, a novel wireless
laparoscopic surgical
camera system, is
small technology with
enormous impact.
Jindong Tan, Ph.D., an associate professor
in Mechanical, Aerospace and Biomedical
Engineering, specializes in robots and medical
imaging and devices. The National Science
Foundation recently recognized the value of the
innovation and awarded $400,000 for further
development.
Surgeons have long relied on camera-tipped
instruments in minimally invasive surgeries.
These, however, are restricted by inflexibility,
immobility or inability to see beyond organs.
They are even less functional with the newer singleincision and natural-orifice surgical techniques.
The sCam is different. This small capsule
is equipped with big technology: A spherical
magnetic head for locomotion; an illumination
and vision subsystem; a wireless communication
subsystem; an inertial sensing system; and a battery
and battery-management system.
For the rest of the story, visit
http://gsm.utmck.edu/research/ibme/main.cfm

Approaching Personalized
Medicine
Collaborations
between engineering
and medicine don’t
only address direct
patient care. One
collaboration is
examining ways
to optimize the
healthcare process to
maximize resources and increase the likelihood of
positive outcomes for patients.
Christopher Stephens, Ph.D., an assistant
professor and research director for iBME; Eman
Abdel Fatah, Ph.D., post-doctoral research associate
at the UT College of Engineering; and others
are leading the effort, with support from Paul
Terry, Ph.D., M.P.H., an associate professor in the
College of Education, Health and Human Sciences.
Simultaneously, Stephens and Fatah are creating
clinical pathways models to understand the steps in
a patient’s treatment process while Terry is directing
research in clinical end points to ensure efficiencies
result in better patient safety and care.

Why this matters:

Looking beyond conventional medical care takes
courage and innovative thinking. These collaborative
efforts will both accelerate and improve medical
solutions for patients in ways rarely conceived
before.
5
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The collaboration of Yong Bradley, M.D.,
an associate professor in Radiology and chief of
the Division of Nuclear Medicine, and Dustin
Osborne, Ph.D., an assistant professor in
Radiology and clinical research director of the
Molecular Imaging and Translational Research
Program, is making a difference in the lives
of patients and causing heads to turn
toward Knoxville.
Recently, the doctors oversaw the installation
at The University of Tennessee Medical Center
of a new and immensely more powerful PET/CT
scanner, called the Biograph mCT. This imaging
technology is the only one of its kind in the
region and sees smaller lesions with more clarity
and reduces image defects that are not related
to the anatomical/molecular image captured by
the mCT scanner. It also accommodates timing

ses o

ft

ow
he p

er f

ul

T
mC

sc a

issues between recorded measurements, making
resulting scans more accurate.
Not only is the new technology currently in
diagnostic use, but is also part of the national
clinical trials network of the Society of Nuclear
Medicine. This network provides improved
access to clinical trials and expands access
to clinical research mechanisms that might
otherwise be unavailable.
One research program involves beta testing
(final stage of testing) a new clinical software that
is FDA-approved for use in PET-CT imaging.
“Testing of this new technology took place in
only two sites in the world, and one is here,”
says Osborne.
Using technology called “continuous bed
motion” (CBM), lesion-detection capabilities
and patient workflow are greatly improved by
6

Technology to Reach Clarity

production,
leading to more
focused imaging.
This compound
has generally
only been used in
prostate cancer
imaging.
“Many believe
that an unusually
high incidence
of pancreatic
cancer exists
in our region,”
Bradley says. He
The new continuous bed motion technology results in improved scans
(right), as compared to the traditional step-and-shoot imaging.
and Osborne are
collaborating with
providing a more fluid image with fewer overlaps.   Keith Gray, M.D., an assistant professor in the
The imaging technologist has better control of
Department of Surgery and chief of the Division
the scan length, which leads to reduced scan
of Surgical Oncology, and the Appalachian
times and up to 5% reduction in radiation dose.
Regional Commission to identify contributing
“The technology allows us more flexibility and
factors of this high incidence rate. They are
reduces the radiation burden for the patient,”
looking at socioeconomic information, treatment
says Bradley.
compliance and social trends of the people in
Since March, more than 100 patients have
the region.
benefitted from the new CBM technology, and
“We will be one of the first to use FCH to image
in May, the team combined CBM technology
pancreatic cancer,” Bradley says. “These images can
with high-definition chest imaging, becoming
help determine treatment strategies and diagnose
the first facility in the world to make this
the cancer at an earlier stage. We believe it also
connection. Chest imaging using this technology
can be used in other cancers and to potentially
results in tailored patient workflows and
determine fast- and slow-growing lesions in
improved diagnostic image quality.
prostate cancer. The use of FCH coupled with our
Bradley and Osborne also are beginning to
expanding work with flurothymidine (FLT) opens
use a better imaging agent, fluorocholine (FCH),
new imaging possibilities.”
with patients who have pancreatic cancer. Unlike
The team also is working to determine if FLT
other glucose-based agents, FCH is absorbed
and FCH do a better job of imaging prostate and
only by cells that show an increase in choline
biliary tract cancers.

Why this matters:

As we are able to find more ways to use the best
technology in the world in concert with keen minds
and curiosity, we are able to provide better care
for patients.
7

Clinical Trials and
Safe, Ethical Research

All research studies using human volunteers must
follow stringent federal regulations and be reviewed
by an Institutional Review Board (IRB) before
being approved. An IRB Committee, comprised of
physicians, pharmacists, scientists, researchers and
non-scientific community representatives, review
research protocol to ensure federal protections are in
place for people volunteering in the study.
The IRB at the UT Graduate School of
Medicine oversees clinical trials, which provide
therapeutic, diagnostic and translational
information. Trials help bring treatments more
rapidly to patients.
Craig Towers, M.D., Maternal-Fetal Medicine,
and others are collaborating with physicians at the
University of South Alabama Medical Center to
investigate whether preservatives (parabens and
triclosans) from cosmetics, lotions and some foods
cross the placenta and if ethnicity plays a role. This
is the first study of its kind in the country. For
more information, contact the Department of
Obstetrics/Gynecology at 865-305-9306.

Rajiv Dhand, M.D., Department of Medicine,
and co-investigators are part of a multi-center
clinical trial to determine if adding inhaled
antibiotics to conventional therapy with
intravenous antibiotics for mechanically ventilated
patients with Gram-negative pneumonia will
improve clinical outcomes. This study is enrolling.
Call Lauren Davis at 865-305-7975.
Melissa Phillips, M.D., Department of Surgery,
is recruiting patients for a post-market observational
study to collect data on the performance of a
new ventral hernia graft technology when used
to reinforce or bridge the abdominal wall for the
repair of ventral hernias. Visit www.clinicaltrials.
gov and search “Hybrid Graft for Ventral Hernia
Repair.” The Department of Surgery also has two
additional hernia-repair trials upcoming. For more
information, call the department at 865-305-9227.

A comprehensive list of clinical trials being
conducted nationwide can be found at
www.clinicaltrials.gov.

Why this matters:

Medical advancements are possible in part because
of clinical trials, and patients can feel assured that
clinical trials are safe and stringently monitored for
adherence to federal regulations.
8

»»»»»»
Anesthesiology Research Looks
for Blood-Borne Answers

In Brief

Robert M. Craft, M.D., and other anesthesiologists research blood coagulation for better patient care.

Anesthesiologists know blood, inside and out.
They administer more blood to patients than any
other group of medical specialists.
For a decade, anesthesiologists at the UT
Graduate School of Medicine have researched
platelet and whole blood functions to find better
care for their patients. Recently, a collaborative
team led by Robert M. Craft, M.D., a professor
and residency program director in the Department
of Anesthesiology, has been investigating blood
coagulation in a variety of clinical situations.
“Traditional tests examine the coagulation
properties of blood’s individual components but
not how they work together,” Craft says. “The
coagulation cascade cannot be adequately assessed
by isolating the parts.”
The team, which also includes, Roger Carroll
Ph.D., and Russell Langdon M.D., is now studying
a process called thromboelastography (TEG) that

determines the rigidity of blood during coagulation
“TEG can tell us which aspect of the coagulation
cascade is at fault and allows us to get these
assessments in real time,” Craft explains.
Craft and team members from various medical
specialties also are using TEG to investigate care in
• Pregnancy and safety with epidurals
• Preconception anticoagulation screenings
• Coagulopathy in massive blood transfusions
• Testing of anticoagulants used for atrial fibrillation
• Coagulation profiles of ischemic and
hemorrhagic stroke
• Anticoagulation inside the brain
• Effect of controlled hypothermia on coagulation
“Our care affects all branches of medicine, so
our research reflects this,” Craft says of the
collaborative spirit evident in the diversity of
research in his department.

Why this matters:

Physicians must understand the actions
and reactions of blood during medical
procedures, and collaborative research led by
anesthesiologists will bolster that understanding
to bring about improved patient safety, better care
and more promising outcomes.
9

In Brief

»»»»»»

Residents in the Lab:
Testosterone, Fractures

and patients make decisions about care pre- and
post-intervention.”
Valerie Sams, M.D., a surgical resident, avidly
pursues research. A recent project involved
collaboration with the Division of Orthopedics and
UT College of Pharmacy.
“Clinicians and surgeons strive to provide pain
control to patients while avoiding use of opiates.
Many orthopedic surgeons, however, believe nonopiate NSAIDs [non-steroidal anti-inflammatory
drugs] impair healing,” Sams explains.
The team investigated whether the use of
NSAIDs after surgery of traumatic long-bone
fractures could result in poor healing of bone
and increase the chance of infection. In their
retrospective study, the team incorporated the
variable of smoking and controlled for other factors.
Findings showed patients with long-bone
fractures who received NSAIDs perioperatively were
more than twice as likely and smokers more than
three times as likely to suffer complications, such as
non- or mal-union of the bone or infection.

Revealing basic-science research at the UT
Graduate School of Medicine is indicating how
testosterone affects the body’s response to
vascular intervention.
Brian Freeman, M.D., a third-year surgical
resident, took a year to study testosterone in
the Vascular Research Laboratory. This lab, led
by Deidra Mountain, Ph.D., already has made
impressive findings on the effect of estrogen on
vascular recovery after intervention.
Freeman’s research in collaboration with the
Division of Urology specifically examines the
role of testosterone deficiency and testosterone
supplementation in the development of intimal
hyperplasia (thickening of the vascular wall)
through abnormal remodeling of the cells using
certain enzymes.
“Although still in the very early stages, our
study could identify low testosterone levels as
a predictor of the incidence of restenosis in
patients prior to vascular intervention,” Freeman
says. “This knowledge would help physicians

Why this matters:

These research initiatives demonstrate how the
UT Graduate School of Medicine is instilling in
medical residents a drive to research to improve
patient outcomes. Both can help patients and
their physicians make safer choices pre- and
post-surgery.
10

In Brief

»»»»»»

Report: Contraceptive Costs and
Unintended Pregnancies

In a 2011 study released by the Centers
for Disease Control and Prevention, 49%
of pregnancies in the U.S. in 2006 were
unintended.  Two physicians at the UT Graduate
School of Medicine are seeking causes.
Audrey Barry, M.D., a fourth-year resident in
the Department of Obstetrics and Gynecology;
Nikki Zite, M.D., an associate professor and
Ob-Gyn residency program director; and
Lorraine Wallace, Ph.D., now at The Ohio State
University, are studying disparities in health care,
particularly disparities in costs for prescription
contraceptives. They presented their findings
at a recent meeting of the American College of
Obstetricians and Gynecologists (ACOG).
“Access to health care, especially access to
contraceptives, is a leading problem for many
women,” says Barry, as reported by ACOG.  “We
believe there is a correlation between high cost

of contraceptives for low-income women and
unintended-pregnancy rates.”
Barry and Zite surveyed costs of the seven
most common prescription contraceptives in the
state of Florida using the website, MyFloridarx.
com. Comparing this with census data, they
were able to compare prices for each zip code
with income levels.
“Virtually all of the prescription contraceptives
we surveyed were more expensive in the lowincome zip codes,” Barry says, “and for two of
the contraceptives, higher-income residents paid
significantly less.”
Although a limited study, Zite believes cost is a
significant barrier to contraceptive use, contributing
to the high unintended-pregnancy rate in the U.S.
“Ensuring that costs of contraceptives are equivalent
among socioeconomic groups could improve access
for all women and result in a healthier community,”
she says.

Why this matters:

Uncovering disparities in access to health
care improves the healthcare system and helps
physicians as advocates for their patients. When
fewer disparities exist, patients can make wiser
choices for their long-term health and the health
of their families.
11
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Golden Idea: Groundbreaking
Radiation Therapy Research

the radioisotope alpha emitter inside of a salt-like
crystal to contain the daughters. This provided
about 50% containment, so the team added layers
of salt-like shell around the crystal. This worked
better, but not well enough.
Then they had the golden idea.
“The Missouri team placed a shell of gold
around the entire particle,” Kennel explains, “and
we’ve seen about 90 percent containment of the
destructive daughters.”
In preclinical testing, Kennel added a binding
agent to the gold shell to allow attachment of an
antibody, which directed the particle containing
the radioisotope to the targeted site, and
injected it into a preclinical model of breast
cancer metastasis.
“In the model, breast cancer tumor cells
growing as metastatic colonies in the lung were
killed,” Kennel says. “We are a long way from
use in the clinic, but this concept is significant.
Learning to bury an isotope in a gold-plated
crystal preventing the escape of radioactive
daughters and subsequent off-target damage is
valuable to further cancer studies.”

For more than 20 years, Stephen Kennel,
Ph.D., an associate professor of Departments
of Medicine and Radiology, has sought a better
way to deliver radioisotopes for the treatment of
cancer, and recently, he and colleagues hit on a
golden idea.
Previously, targeted radiotherapy (using
radioactive isotopes injected into the body to kill
targeted cancer cells) used beta agents, which have
limited potency. Kennel and Saed Mirzadeh,
Ph.D., a senior scientist at the Oak Ridge National
Laboratory, and other medical researchers believed
using alpha-emitting radioisotopes, which kill
more efficiently, would improve results.
“When many of the alpha-emitting
radioisotopes decay, however, they produce
‘daughters’, generated by the original ‘parent’
radioisotope,” Kennel says. “The radioactive
daughters stray from the parent and can damage
surrounding normal tissue.”
Kennel and Mirzadeh, along with researchers at
the University of Missouri tested a theory: Entrap

Why this matters:

Medical breakthroughs often come on the
shoulders of research done at the basic-science
level, and this finding can lead to better ways to
target cancer cells without damaging surrounding
organs.
12

News»

Nutrition Research Funding Renewed

Collaboration Garners Top Finish

Christy M. Lawson, M.D.,
an assistant professor
in the Department of
Surgery, recently presented
the initial phase results of
her Norman Yoshimura
Grant by B Braun and
the Aesculap Academy
research award from the
Rhoads Foundation of
the American Society of
Parenteral and Enteral
Christy M. Lawson, M.D.
Nutrition at Clinical
Nutrition Week in Phoenix, Ariz. Her ongoing
project was funded for another year based upon the
exciting results of “Cross Talk Between Renin and
Angiotensin in Burn Trauma.” A co-investigator
is Michael Karlstad, Ph.D., a professor in the
Department of Surgery.

Collaboration in the Physionet 2012 competition,
one of the premier events focusing on computer
applications in clinical cardiology and cardiovascular
research, generated a top finish. The team
comprised of University of Tennessee, Knoxville,
representatives Henian Xia, Xiaoping Zhao and
Adam Petrie, and UT Graduate School of Medicine
Professor of Surgery Brian Daley, M.D., combined
clinical and engineering expertise to develop a model
for mortality prediction based on a new and blinded
outcome ICU data set. The project’s results are
published in Computing in Cardiology.

Concussion Research Links
Genetic Markers
Ongoing and important research on concussion
is the first to link two genetic markers to postconcussion neurocognitive function and outcome.
Tom Terrell, M.D., an associate professor in the
department of Family Medicine Sports Medicine
Program, studied more than 3,000 college football
and soccer athletes and believes this is a step closer to
understanding the link between genetic factors and
neurocognitive outcome for concussion in contactsport athletes, as reported by the American Medical
Society of Sports Medicine. The research received
funding from the National Operating Committee
on Standards for Athletic Equipment.

Radiology Residents’
Research Awarded
Residents in the Department of Radiology earned
first-place finishes in recent research presentations.
Katherine Frederick-Dyer, M.D., was awarded a first
place trainee award by the Association of University
Radiologists for her project “The Effect on Patient
Radiation Dose of a Formal Fluoroscopy Privileging
Program in First Fluoroscopy Rotations.” Austin
Bourgeois, M.D., placed first for his presentation
“Increased Accuracy in Lumbar Pedicle Screw
Placement Using Three-Dimensional Image
Guidance” at the 2013 American Society of Spinal
Radiology Annual Meeting.

Dhand Re-elected
to International
Society
Rajiv Dhand, M.D., chair
of the Department of
Medicine, recently was
re-elected to the Executive
Board of the International
Society of Aerosols in
Medicine.
Rajiv Dhand, M.D.

Your Chance to Advance
The people at the UT Graduate School of Medicine would be happy to discuss
our research programs and how your support can help advance health care. For
information about philanthropic giving to the UT Graduate School of Medicine
Office of Research, please contact the development office at 865-305-6611 or
development@utmck.edu.
If you would like more information about any of the research programs described
in this issue of Advance, please contact the UT Graduate School of Medicine at
865-305-9290 or visit us online: http://gsm.utmck.edu/research/main.cfm.
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